The Discounted Cash Flow (DCF) valuation of Biohit Oyj (BIOBV.HE) is 3.95 EUR. With the latest stock price at 2.70 EUR, the upside of Biohit Oyj based on DCF is 46.4%.
Based on the latest price of 2.70 EUR and our DCF valuation, Biohit Oyj (BIOBV.HE) is a buy. buying BIOBV.HE stocks now will result in a potential gain of 46.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.8% | 7.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 2.69 - 8.32 | 3.95 |
| Upside | -0.3% - 208.2% | 46.4% |